KOLM THERAPEUTICS Trademark

Trademark Overview


On Thursday, May 9, 2024, a trademark application was filed for KOLM THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the KOLM THERAPEUTICS trademark a serial number of 98541872. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Sunday, November 24, 2024. This trademark is owned by Kolm Therapeutics Inc.. The KOLM THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

therapeutic pharmaceuticals for the treatment of cancer and autoimmune diseases; pharmaceutical products for the prevention and treatment of cancer; anti-cancer preparations; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases; pharmaceuticals comprising small molecules for the treatment of cancer and autoimmune diseases

scientific research for medical purposes in the fields of oncology and autoimmune diseases; research and development of therapeutics for the treatment of cancer and autoimmune diseases; research and development in the field of small molecule drug discovery; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development; drug discovery services; pharmaceutical research and development services; research and development in the field of precision medicine

General Information


Serial Number98541872
Word MarkKOLM THERAPEUTICS
Filing DateThursday, May 9, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateSunday, November 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicestherapeutic pharmaceuticals for the treatment of cancer and autoimmune diseases; pharmaceutical products for the prevention and treatment of cancer; anti-cancer preparations; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases; pharmaceuticals comprising small molecules for the treatment of cancer and autoimmune diseases
Goods and Servicesscientific research for medical purposes in the fields of oncology and autoimmune diseases; research and development of therapeutics for the treatment of cancer and autoimmune diseases; research and development in the field of small molecule drug discovery; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development; drug discovery services; pharmaceutical research and development services; research and development in the field of precision medicine

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 9, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 9, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKolm Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoodbridge, CT 06525

Trademark Events


Event DateEvent Description
Thursday, May 9, 2024NEW APPLICATION ENTERED
Thursday, November 7, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 22, 2024ASSIGNED TO EXAMINER
Sunday, November 24, 2024NON-FINAL ACTION WRITTEN
Sunday, November 24, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, November 24, 2024NON-FINAL ACTION E-MAILED